Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

PTC Therapeutics Inc. buy JPMorgan Chase & Co.

Start price
€35.00
21.05.24 / 50%
Target price
€48.82
21.05.25
Performance (%)
-12.57%
Price
€30.60
25.07.24
Summary
This prediction is currently active. The prediction for PTC Therapeutics Inc. disappoints with a performance of -12.57%. This prediction currently runs until 21.05.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
PTC Therapeutics Inc. 1.987% 1.987%
iShares Core DAX® 0.039% 0.567%
iShares Nasdaq 100 -4.018% -5.554%
iShares Nikkei 225® -2.389% -1.434%
iShares S&P 500 -2.115% -2.351%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread PTC Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -12.57%
Target price 48.818
Change
Ends at 21.05.25

PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat

Stopped prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc.

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€31.20
20.06.24
€49.47
20.06.25
-2.56%
25.07.24